CombiScreen® mALB / CREA

CombiScreen® mALB / CREA

CombiScreen® mALB / CREA

Product catalog summary
Product Overview: CombiScreen® mALB / CREA is a diagnostic tool designed for the detection of microalbuminuria, particularly in patients with chronic conditions such as diabetes and high blood pressure. It measures the albumin-to-creatinine ratio in urine, providing accurate information regardless of urine concentration.
Key Features:
  • Agile and Cost-effective: The test is quick, with results available in 60 seconds, eliminating the need for 24-hour urine collection.
  • High Sensitivity: The test has a low detection limit of 22 mg/L for albumin, making it suitable for reliable screening of at-risk patients.
  • Extended Range: Capable of detecting both microalbuminuria and macroalbuminuria with an albumin concentration range up to 500 mg/L.
Intended Use: The test is intended for screening microalbuminuria in individuals with chronic conditions that increase the risk of kidney disease. It is suitable for use during physician, clinic, or hospital visits.
Procedure:
  • Utilizes spontaneous voided urine, preferably morning samples.
  • Results can be visually interpreted using a provided table or automatically calculated with the Urilyzer® 100 Pro.
Considerations: Testing should be repeated if conditions such as blood in urine, urinary tract infections, vigorous exercise, acute illnesses, preeclampsia, dehydration, or drug interference are present.
Ease of Use: The test is designed for simplicity, with no need for complex calculations or laboratory processing, making it accessible for immediate use in various healthcare settings.
See more

Catalog excerpts

CombiScreen® mALB / CREA-1

CombiScreen® mALB / CREA Content: 25 pcs.  Art.-No: 94025 The albumin-to-creatinine ratio provides accurate information about the albumin level in urine, regardless of the urine concentration. The low detection limit of 22 mg/L albumin enables reliable screening of risk patients. Cost-effective and fast method. No 24 h sample collection is necessary. agile - affordable - accurate

 Open the catalog to page 1
CombiScreen® mALB / CREA-2

„Measurement of the albumin-to-creatinine ratio in a random spot collection is often found to be the easiest to carry out in an office setting, generally provides accurate information, and is therefore preferred.“ (Nephropathy in Diabetes, American Diabetes Association, Diabetes Care 2004 Jan, 27 (Suppl. 1): S79–S83) Screening of microalbuminuria in people with chronic conditions, such as diabetes and high blood pressure that puts them at an increased risk of developing a kidney disease. It may also be associated with some lipid abnormalities and various immune disorders. Screening immediately...

 Open the catalog to page 2

All Analyticon Biotechnologies GmbH catalogs and technical brochures

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.